Galectin Therapeutics Correlations
GALT Stock | USD 1.15 0.28 32.18% |
The current 90-days correlation between Galectin Therapeutics and Milestone Pharmaceuticals is 0.15 (i.e., Average diversification). The correlation of Galectin Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Galectin |
Moving together with Galectin Stock
0.74 | DNLI | Denali Therapeutics | PairCorr |
0.73 | DOMH | Dominari Holdings | PairCorr |
0.75 | DTIL | Precision BioSciences | PairCorr |
0.71 | VIGL | Vigil Neuroscience | PairCorr |
0.61 | VRDN | Viridian Therapeutics | PairCorr |
0.66 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.73 | VRTX | Vertex Pharmaceuticals | PairCorr |
Moving against Galectin Stock
0.77 | CDIOW | Cardio Diagnostics | PairCorr |
0.71 | DRTS | Alpha Tau Medical | PairCorr |
0.67 | DMAC | DiaMedica Therapeutics | PairCorr |
0.41 | VCYT | Veracyte | PairCorr |
0.4 | SABSW | SAB Biotherapeutics | PairCorr |
0.37 | VCEL | Vericel Corp Ord | PairCorr |
0.37 | DSGN | Design Therapeutics | PairCorr |
0.62 | VRNA | Verona Pharma PLC | PairCorr |
0.56 | DYAI | Dyadic International | PairCorr |
0.34 | DVAX | Dynavax Technologies | PairCorr |
0.31 | VTYX | Ventyx Biosciences | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Galectin Stock performing well and Galectin Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Galectin Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
MDGL | 2.58 | 0.62 | 0.26 | 0.65 | 1.96 | 5.17 | 30.27 | |||
VKTX | 3.23 | (0.55) | 0.00 | (0.72) | 0.00 | 5.82 | 39.28 | |||
SRPT | 1.82 | (0.02) | 0.00 | (0.03) | 0.00 | 3.75 | 18.21 | |||
HEPA | 3.71 | (0.47) | 0.00 | 1.05 | 0.00 | 8.06 | 35.17 | |||
PTCT | 2.86 | 0.38 | 0.14 | 0.87 | 2.35 | 7.02 | 23.95 | |||
ICPT | 2.96 | (0.77) | 0.00 | 1.42 | 0.00 | 5.23 | 38.17 | |||
TERN | 3.04 | (0.65) | 0.00 | (1.53) | 0.00 | 5.17 | 26.61 | |||
AKRO | 2.64 | 0.05 | 0.01 | 0.34 | 3.12 | 5.23 | 13.97 | |||
RETA | 2.22 | 0.21 | 0.05 | (0.32) | 3.31 | 5.24 | 28.80 | |||
DMAC | 3.34 | 0.53 | 0.13 | 2.38 | 3.49 | 8.64 | 47.69 |
Galectin Therapeutics Corporate Management
CPA CPA | Treasurer CFO | Profile | |
Khurram MD | Chief Officer | Profile | |
Jeff Katstra | Head Development | Profile | |
Robert Tritt | General Counsel | Profile | |
Beth Knowles | Executive Manager | Profile |